Xtalks Announces its Life Science Webinar Calendar for March 2026
Upcoming free, educational webinars from Xtalks will feature topics in cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, laboratory technology, medical device, pharma manufacturing & supply chain and pharmaceutical regulation.
Visit www.xtalks.com to see our upcoming webinars:
CELL AND
CLINICAL TRIALS
COMMERCIALIZATION & HEOR
DRUG DISCOVERY & DEVELOPMENT
LABORATORY TECHNOLOGY
MEDICAL DEVICE
PHARMA MANUFACTURING & SUPPLY CHAIN
PHARMACEUTICAL REGULATION
ABOUT XTALKS
Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Tel: +1 (416) 977-6555 x272
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/xtalks-announces-its-life-science-webinar-calendar-for-march-2026-302700523.html
SOURCE Xtalks
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 12 Press Releases You Need to See This Week
- Breaking News: Legal Bay Pre Settlement Funding Announces $40MM Jury Verdict in Bard PowerPort Trial
- Cooling Mattress (2026): NELL Named for Japanese Craftsmanship and Breathable Sleep Design by Consumer365
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share